Initial Innovations to be Featured at 2022
ASTRO Annual Meeting
MELBOURNE, Fla., Oct. 19,
2022 /PRNewswire/ -- Sun Nuclear, a wholly-owned
subsidiary of Mirion Technologies, Inc. (NYSE: MIR) ("Mirion"),
today announced that it is developing new Quality Management
solutions, in collaboration with Accuray, for the company's
Radixact® System with Synchrony®, which enables real-time,
personalized adaptive radiation therapy. Initial innovations from
the collaboration will be featured in the Sun Nuclear booth (980)
at the ASTRO Annual Meeting, October 23-25,
2022, in San Antonio,
Texas.
The Enhanced Dynamic Platform, the first release to come
from the expanded partnership, is a next-generation design of the
Dynamic Platform from CIRS, now part of Sun Nuclear. It enables
movement of compatible phantoms with sub-millimeter accuracy and
reproducibility, easing quality assurance (QA) and boosting
clinical confidence for advanced tumor treatments.
The Enhanced Dynamic Platform allows for precisely controlled
inferior-superior motion and features the ability to create an
inclined plane for compatible phantom motion in the
posterior-anterior direction. An independently controlled smaller
platform provides surrogate chest wall motion. CIRS Motion
Control Software enables different cycles, amplitudes, and
waveforms – as well as the import of patient-specific respiratory
waveforms.
The Enhanced Dynamic Platform integrates with the Sun Nuclear
Tomo-Phantom HE ("Cheese Phantom"), supporting the Accuray
acceptance tests procedure (ATP), as handled by the legacy Dynamic
Platform.
Also on display in the Sun Nuclear ASTRO booth will be the
work-in-progress MotionCHECK™ 3D System. Designed to support
the tumor tracking capabilities of Synchrony®, MotionCHECK 3D is
intended to integrate the Enhanced Dynamic Platform with the
ArcCHECK® array, the benchmark for 3D pre-treatment patient QA
in radiation therapy.
The Radixact Treatment Delivery System provides a
fully-integrated platform for treatment planning, data management
and treatment delivery, and supports multiple precise treatment
techniques, including motion synchronized radiation therapy. For
these delivery types, Accuray's Synchrony® real-time motion
synchronization technology enables clinics to treat patients
without any ITV (Internal Target Volume), with no gating, and with
automated tumor tracking. Unique to Synchrony is a sophisticated
AI-based predictive modeling of the target position that brings the
beam steering in synch with the target motion.
"We are excited to highlight the Enhanced Dynamic Platform and
MotionCHECK 3D system at ASTRO," notes Mark
Rose, Ph.D., Sun Nuclear Director of Product Management.
"For departments using respiratory motion management delivery
techniques, the appropriate QA tools are vital to ensuring patient
safety. We are confident Sun Nuclear's benchmark ArcCHECK array
combined with CIRS' proven motion platform will deliver a strong
solution for QA of motion management."
"We have collaborated often with Sun Nuclear on QA solutions
specific to the technologies that Accuray produces. Now with their
expanded motion management portfolio, we are excited to work with
them again on a solution for our Radixact® System with Synchrony®
and look forward to collaborating on other motion management
QA solutions in the future," said Dylan
Casey, Ph.D., Senior Director, Medical Physics and Systems
Analysis at Accuray Incorporated.
About Sun Nuclear
Sun Nuclear and CIRS are part of Mirion Medical, a group of
healthcare-focused brands within Mirion Technologies (NYSE:
MIR). We provide innovative solutions for Radiation Therapy
and Diagnostic Imaging centers. More than 5,000 cancer centers
worldwide rely on us for independent, integrated Quality
Management. With a focus on ongoing support, Sun Nuclear aims to
ease technology adoption, enhance workflows and improve outcomes –
so that healthcare providers can achieve real results for Patient
Safety. Visit us: sunnuclear.com and cirsinc.com. Follow us:
@sunnuclear.
Contacts
For investor
inquiries:
Jerry Estes
ir@mirion.com
For media inquiries:
Kevin
O'Malley
komalley@mirion.com
*MotionCHECK™ 3D is a work in progress from Sun Nuclear and
CIRS, in partnership with Accuray Incorporated.
Sun Nuclear, ArcCHECK, and MotionCHECK are registered
trademarks of Mirion Technologies, Inc. and/or its affiliates in
the United States and/or other
countries.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/sun-nuclear-partners-with-accuray-to-develop-new-quality-management-solutions-for-the-radixact-system-with-synchrony-301652677.html
SOURCE Sun Nuclear Corporation